2437 Stock Overview
Harbin Gloria Pharmaceuticals Co., Ltd engages in the research, development, production, and sale of pharmaceutical products primarily in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
HARBIN GLORIA PHARMACEUTICALS Co., LTD Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥2.13 |
| 52 Week High | CN¥3.15 |
| 52 Week Low | CN¥1.67 |
| Beta | 0.39 |
| 1 Month Change | 10.94% |
| 3 Month Change | 8.12% |
| 1 Year Change | -5.75% |
| 3 Year Change | -22.26% |
| 5 Year Change | -46.48% |
| Change since IPO | -46.15% |
Recent News & Updates
Shareholder Returns
| 2437 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -2.3% | -2.9% | -1.5% |
| 1Y | -5.8% | -9.2% | -11.3% |
Return vs Industry: 002437 exceeded the CN Pharmaceuticals industry which returned -9.1% over the past year.
Return vs Market: 002437 exceeded the CN Market which returned -11.3% over the past year.
Price Volatility
| 2437 volatility | |
|---|---|
| 2437 Average Weekly Movement | 4.7% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in CN Market | 10.8% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 002437 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002437's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 3,085 | Leifeng Guo | www.gloria.cc |
Harbin Gloria Pharmaceuticals Co., Ltd engages in the research, development, production, and sale of pharmaceutical products primarily in the People’s Republic of China. It offers cardiac cerebrovascular medication, skeletal muscle system, vitamins and minerals, urinary system medication, antitumor medication, endocrine medicine, anti-infective drugs, respiratory medication, antihistamine, peptic, and other products. Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is based in Harbin, the People’s Republic of China.
HARBIN GLORIA PHARMACEUTICALS Co., LTD Fundamentals Summary
| 2437 fundamental statistics | |
|---|---|
| Market cap | CN¥4.84b |
| Earnings (TTM) | CN¥152.56m |
| Revenue (TTM) | CN¥2.54b |
31.7x
P/E Ratio1.9x
P/S RatioIs 2437 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2437 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.54b |
| Cost of Revenue | CN¥1.08b |
| Gross Profit | CN¥1.46b |
| Other Expenses | CN¥1.30b |
| Earnings | CN¥152.56m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.067 |
| Gross Margin | 57.35% |
| Net Profit Margin | 6.01% |
| Debt/Equity Ratio | 22.8% |
How did 2437 perform over the long term?
See historical performance and comparison